Lidocaine/prilocaine topical - AstraZeneca

Drug Profile

Lidocaine/prilocaine topical - AstraZeneca

Alternative Names: Emla Patch; Emlapatch

Latest Information Update: 24 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class Acetanilides; Anilides; Erectile dysfunction therapies; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anaesthesia

Most Recent Events

  • 09 Nov 2017 AstraZeneca completes a phase I trial for Anaesthesia (In volunteers) in Germany (NCT03313336)
  • 30 Oct 2017 Phase-I clinical trials in Anaesthesia (In volunteers) in Germany (Topical) (NCT03313336)
  • 24 Oct 2017 AstraZeneca plans a phase I trial for Anaesthesia (In volunteers) in Germany (NCT03313336)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top